5.81
price up icon3.75%   0.21
after-market Dopo l'orario di chiusura: 5.85 0.04 +0.69%
loading
Precedente Chiudi:
$5.60
Aprire:
$5.7
Volume 24 ore:
1.55M
Relative Volume:
1.24
Capitalizzazione di mercato:
$589.57M
Reddito:
-
Utile/perdita netta:
$-168.09M
Rapporto P/E:
-2.6774
EPS:
-2.17
Flusso di cassa netto:
$-138.01M
1 W Prestazione:
+0.17%
1M Prestazione:
-7.78%
6M Prestazione:
-33.06%
1 anno Prestazione:
-71.77%
Intervallo 1D:
Value
$5.645
$5.995
Intervallo di 1 settimana:
Value
$5.575
$5.995
Portata 52W:
Value
$5.41
$23.48

Kura Oncology Inc Stock (KURA) Company Profile

Name
Nome
Kura Oncology Inc
Name
Telefono
(858) 500-8800
Name
Indirizzo
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Name
Dipendente
192
Name
Cinguettio
@kuraoncology
Name
Prossima data di guadagno
2025-02-21
Name
Ultimi documenti SEC
Name
KURA's Discussions on Twitter

Confronta KURA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KURA
Kura Oncology Inc
5.81 589.57M 0 -168.09M -138.01M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-06 Downgrade BTIG Research Buy → Neutral
2024-10-24 Iniziato UBS Buy
2024-10-14 Downgrade Stifel Buy → Hold
2023-12-22 Iniziato Mizuho Buy
2023-08-11 Iniziato BofA Securities Buy
2023-07-27 Iniziato Scotiabank Sector Perform
2023-05-17 Iniziato BTIG Research Buy
2023-01-31 Iniziato Stifel Buy
2022-07-12 Iniziato Cantor Fitzgerald Overweight
2022-02-15 Iniziato Jefferies Buy
2021-05-05 Ripresa Credit Suisse Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2020-12-07 Reiterato H.C. Wainwright Buy
2020-12-03 Iniziato Stifel Buy
2020-11-05 Downgrade Piper Sandler Overweight → Neutral
2020-07-07 Iniziato Credit Suisse Outperform
2020-05-05 Iniziato Barclays Overweight
2019-07-18 Iniziato Deutsche Bank Buy
2018-11-09 Iniziato Piper Jaffray Overweight
2018-08-01 Iniziato H.C. Wainwright Buy
2016-10-13 Ripresa Leerink Partners Outperform
2016-01-22 Iniziato JMP Securities Mkt Outperform
2015-12-30 Iniziato Oppenheimer Outperform
2015-12-16 Iniziato Citigroup Buy
Mostra tutto

Kura Oncology Inc Borsa (KURA) Ultime notizie

pulisher
Jun 18, 2025

Transcript : Kura Oncology, Inc.Special Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Kura Oncology Announces Positive Phase 1a/1b Trial Results - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (KURA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Kura Oncology rises after new early-stage trial data for leukemia therapy - MSN

Jun 17, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Invests $66,000 in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook - Investing.com Canada

Jun 13, 2025
pulisher
Jun 12, 2025

KURA's Ziftomenib Shows Promising Results in AML Clinical Trial - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Is the Options Market Predicting a Spike in Kura Oncology Stock? - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology (KURA) Shows Promising Results for AML Therapy - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology Says Ziftomenib Study Achieves Complete Remission in Acute Myeloid Leukemia - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology stock rises on leukemia drug data (KURA:NASDAQ) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Is The Options Market Predicting A Spike In Kura Oncology Stock? - Barchart.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combinatio - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Strong Results from KOMET-007 Trial of Ziftomenib in Newly Diagnosed AML Patients - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly ... - Enidnews.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Kura Oncology FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

KURA Stock Rises More Than 15% This Past Week: Here's Why - MSN

Jun 11, 2025
pulisher
Jun 10, 2025

Kura Oncology at Goldman Sachs Conference: Strategic Insights on ZIFTOMENIB - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Kura Oncology, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 11 - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Acquires New Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Kura Oncology Stockholders Approve Equity Plan Amendment - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Grants Stock Options To New Hires Under Inducement Plan - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rul - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology (KURA) Grants Stock Options to New Employees | KUR - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology (KURA) Grants Stock Options to New Employees | KURA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KURA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Expands Cancer Research Team with Strategic Stock Options for 5 Key New Hires - Stock Titan

Jun 06, 2025
pulisher
Jun 05, 2025

Kura Oncology’s (KURA) “Market Outperform” Rating Reaffirmed at JMP Securities - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Kura Oncology at Jefferies Conference: Strategic Advancements in AML By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

**citizens jmp reiterates market outperform rating on kura oncology stock** - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Sells 42,120 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Rising Leaders 2025: Kura Oncology’s Mollie Leoni On Setting Precedent, Not Following It - insights.citeline.com

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Lowers Stock Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Transcript : Kura Oncology, Inc. Presents at American Society of Clinical Oncology Annual Meeting 2025, Jun-02-2025 06 - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology Drug’s Data at ASCO Support FDA Filing Now Under Priority Review for Leukemia - MedCity News

Jun 03, 2025
pulisher
Jun 03, 2025

KURA: Optimism for Kura Oncology's Menin Inhibitor Grows with FDA Priority Review | KURA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cantor Fitzgerald reiterates overweight rating for Kura Oncology stock By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology reports positive trial results for AML treatment By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology at ASCO: Strategic Moves in AML Treatment By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 02, 2025

Kura Oncology reports positive trial results for AML treatment - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

KURA: Promising Results for Kura Oncology's AML Therapy at ASCO Meeting | KURA Stock News - GuruFocus

Jun 02, 2025

Kura Oncology Inc Azioni (KURA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Kura Oncology Inc Azioni (KURA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
FORD KATHLEEN
Chief Operating Officer
May 19 '25
Sale
6.28
1,558
9,777
21,367
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):